Rothschild Capital Partners LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Rothschild Capital Partners LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 596 shares of the medical equipment provider's stock, valued at approximately $311,000.

Other institutional investors have also added to or reduced their stakes in the company. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical in the fourth quarter worth about $82,517,000. Sycomore Asset Management lifted its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after buying an additional 4,079 shares during the period. Exome Asset Management LLC boosted its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its holdings in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after acquiring an additional 525 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 1.3 %

ISRG stock traded up $6.46 during trading on Friday, reaching $514.59. The stock had a trading volume of 2,015,889 shares, compared to its average volume of 1,617,024. The stock's 50 day moving average is $511.92 and its two-hundred day moving average is $533.05. The firm has a market cap of $183.29 billion, a PE ratio of 80.28, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52 week low of $367.39 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the business posted $1.50 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 35,454 shares of company stock worth $18,564,027 in the last three months. Corporate insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research reports. Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday. Evercore ISI decreased their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank raised their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Finally, UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.